明基醫

-0.30 (-0.75%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

39.606成交張數15.00本益比1.60股價淨值比5.05%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	55	11	58.8%	1.52	24.74	10.9%	2.2%	1.5	1.4
2026Q1	56	10	59.9%	1.59	23.50	6.5%	1.3%	0.3	0.2
2025Q4	55	11	57.2%	1.62	25.28	7.0%	1.5%	1.1	0.8
2025Q3	52	11	57.8%	1.83	24.48	7.8%	1.7%	1.2	1.1
2025Q2	53	11	59.7%	1.58	23.67	8.0%	1.7%	1.8	1.7
2025Q1	53	11	57.4%	1.68	24.08	9.9%	2.1%	-0.5	-0.9
2024Q4	53	11	56.4%	1.75	25.18	9.4%	2.1%	0.9	0.4
2024Q3	50	11	54.6%	1.82	24.64	10.7%	2.4%	0.8	0.6
2024Q2	46	11	54.6%	1.83	23.89	11.4%	3.2%	0.2	-0.5
2024Q1	47	10	54.5%	1.83	23.22	10.6%	2.9%	0.3	0.0
2023Q4	47	11	53.7%	1.99	24.68	10.0%	2.8%	2.7	2.5
2023Q3	46	11	54.1%	1.96	23.91	9.0%	2.5%	0.8	0.4
2023Q2	32	11	48.4%	1.58	25.67	8.6%	3.0%	0.6	0.4
2023Q1	34	11	50.8%	1.56	25.31	10.3%	3.5%	0.3	-0.2
2022Q4	34	12	48.9%	1.72	26.90	16.1%	6.7%	1.4	1.2
2022Q3	33	12	49.2%	1.73	26.36	15.4%	6.7%	1.3	1.0
2022Q2	32	11	49.2%	1.66	25.57	13.3%	5.8%	0.7	0.6
2022Q1	33	11	50.3%	1.62	24.80	10.3%	4.4%	0.4	0.4
2021Q4	20	10	43.8%	1.88	23.29	2.8%	1.5%	0.7	0.6
2021Q3	18	10	38.6%	1.70	23.02	4.7%	2.8%	0.3	0.3
2021Q2	17	10	38.8%	1.52	22.83	5.3%	3.1%	0.4	0.3
2021Q1	18	11	36.6%	1.67	23.76	5.6%	3.4%	-0.2	-0.3
2020Q4	18	11	37.8%	1.66	23.65	5.9%	3.6%	1.1	0.9
2020Q3	17	10	38.0%	1.73	22.89	5.3%	3.2%	0.6	0.5
2020Q2	17	10	39.1%	1.49	22.55	5.9%	3.5%	-0.0	-0.1
2020Q1	17	11	34.1%	1.78	23.73	5.9%	3.8%	-0.2	-0.2
2019Q4	17	11	34.6%	1.58	23.57	7.2%	4.5%	0.2	0.2
2019Q3	17	10	35.1%	1.64	23.04	7.9%	5.0%	0.8	0.8
2019Q2	16	10	35.4%	1.37	22.64	7.7%	4.9%	0.5	0.4
2019Q1	16	11	32.0%	1.53	23.73	7.9%	5.2%	0.2	0.1
2018Q4	17	10	35.0%	2.06	23.26	6.5%	4.1%	0.9	0.7
2018Q3	15	10	31.1%	1.52	22.64	5.5%	3.6%	0.4	0.4
2018Q2	15	10	30.3%	1.51	22.30	5.0%	3.3%	0.1	0.1
2018Q1	15	10	28.0%	1.71	22.94	4.5%	3.2%	-0.1	-0.2
2017Q4	15	10	30.8%	1.58	22.82	4.6%	3.2%	-0.1	-0.2
2017Q3	15	10	30.3%	1.44	22.40	4.5%	3.1%	0.5	0.1
2017Q2	15	10	30.0%	1.51	22.27	4.3%	2.9%	0.3	0.1
2017Q1	13	10	24.6%	1.94	22.55	4.2%	3.1%	-0.1	-0.4
2016Q4	14	10	26.9%	1.85	22.54	–	–	0.4	0.2
2016Q3	13	10	26.3%	1.87	22.25	–	–	0.4	-0.5